Intra-Epicaine 20 mg/ml Solution for Injection for Horses

Država: Velika Britanija

Jezik: engleski

Izvor: VMD (Veterinary Medicines Directorate)

Aktivni sastojci:

Mepivacaine Hydrochloride

Dostupno od:

Dechra Limited

ATC koda:

QN01BB03

INN (International ime):

Mepivacaine Hydrochloride

Farmaceutski oblik:

Solution for injection

Tip recepta:

POM-V - Prescription Only Medicine – Veterinarian

Terapijska grupa:

Horses

Područje terapije:

Neurological Agent local anaesthetic

Status autorizacije:

Authorized

Datum autorizacije:

1990-12-20

Svojstava lijeka

Revised: August 2015
AN: 00503/2015
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Intra-Epicaine 20 mg/ml Solution for Injection for Horses
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains :
Active substance:
Mepivacaine hydrochloride
20 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
A clear colourless mobile liquid, practically free from visible
particles.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Mepivacaine is indicated for infiltration, nerve block,
intra-articular and epidural
anaesthesia in horses.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Care should be taken to avoid intra-vascular injection by aspiration
prior to and
during administration.
Revised: August 2015
AN: 00503/2015
Page 2 of 5
The analgesic effect of mepivacaine, when used as part of a lameness
investigation, begins to subside after 45-60 minutes. However,
sufficient analgesia
may persist to effect gait beyond two hours.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Care should be taken to avoid accidental self-injection or skin
contact.
In the event of accidental self-injection medical advice should be
sought.
Wash splashes from skin or eyes immediately.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Transient, local soft tissue swelling may occur in a small proportion
of cases
following injection of the product.
Local anaesthetics used in excess can cause systemic toxicity
characteristics by
CNS effects.
If systemic toxicity occurs, as a result of inadvertent intra-vascular
injection, the
administration of oxygen to treat cardio-respiratory depression and
diazepam to
control convulsions should be considered.
8.
USE DURING PREGNANCY, LACTATION OR LAY
Not contraindicated.
9.
INTERACTION WITH OTHER MEDICINAL PRO